These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2561098

  • 21. Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer. A prospective study.
    Javadpour N, Young JD.
    Urology; 1992 Jul; 40(1):7-8. PubMed ID: 1320303
    [Abstract] [Full Text] [Related]

  • 22. Postchemotherapy residual masses in germ cell tumor patients: our experience.
    Morelli F, Tozzi L, Setola P, Bisceglia M, Barbini VR, Maiello E.
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii132-6. PubMed ID: 16760276
    [Abstract] [Full Text] [Related]

  • 23. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
    Ramani VA, Grey BR, Addla SK, Dunham MP, Sangar VK, Clarke NW.
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
    [Abstract] [Full Text] [Related]

  • 24. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
    Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ.
    Cancer; 1998 Apr 01; 82(7):1343-51. PubMed ID: 9529027
    [Abstract] [Full Text] [Related]

  • 25. Postchemotherapy surgery in nonseminomatous testicular tumors.
    Hornák M, Ondrus D, Matoska J, Cársky S.
    Eur Urol; 1996 Apr 01; 29(3):325-30. PubMed ID: 8740018
    [Abstract] [Full Text] [Related]

  • 26. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors.
    Tiffany P, Morse MJ, Bosl G, Vaughan ED, Sogani PC, Herr HW, Whitmore WF.
    Cancer; 1986 Mar 01; 57(5):978-83. PubMed ID: 3002596
    [Abstract] [Full Text] [Related]

  • 27. Management of post-chemotherapy extra-retroperitoneal residual masses.
    Carver BS, Sheinfeld J.
    World J Urol; 2009 Aug 01; 27(4):489-92. PubMed ID: 19373472
    [Abstract] [Full Text] [Related]

  • 28. Predictors of residual mass histology after chemotherapy for advanced testis cancer.
    Sagalowsky AI, Ewalt DH, Molberg K, Peters PC.
    Urology; 1990 Jun 01; 35(6):537-42. PubMed ID: 2162091
    [Abstract] [Full Text] [Related]

  • 29. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
    Miki T, Saki S, Kotake T.
    Hinyokika Kiyo; 1994 Oct 01; 40(10):951-5. PubMed ID: 7992713
    [Abstract] [Full Text] [Related]

  • 30. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD, Aass N, Ous S, Høie J, Stenwig AE, Lien HH, Paus E, Kaalhus O.
    J Urol; 1989 Nov 01; 142(5):1239-42. PubMed ID: 2478726
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
    Culine S, Theodore C, Court BH, Perrin JL, Droz JP.
    Br J Urol; 1997 Feb 01; 79(2):258-62. PubMed ID: 9052479
    [Abstract] [Full Text] [Related]

  • 32. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T, Goepel M, Seeber S, Rübben H.
    Urologe A; 1993 May 01; 32(3):189-93. PubMed ID: 7685554
    [Abstract] [Full Text] [Related]

  • 33. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J, Martínez-Silva V, Domínguez-Esteban M, de la Rosa-Kehrmann F, Villacampa-Aubá F, Castellano-Gauna D, Díaz-González R.
    Arch Esp Urol; 2011 Sep 01; 64(7):611-9. PubMed ID: 21965259
    [Abstract] [Full Text] [Related]

  • 34. Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.
    Pentheroudakis G, De Bono JS, Kaye SB, Simpson A, Paul J, Brown I, Pamenter B, Kirk A, Vasey P, Raby N, Kirk D.
    BJU Int; 2003 Jul 01; 92(1):36-42. PubMed ID: 12823380
    [Abstract] [Full Text] [Related]

  • 35. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
    Rick O, Bokemeyer C, Weinknecht S, Schirren J, Pottek T, Hartmann JT, Braun T, Rachud B, Weissbach L, Hartmann M, Siegert W, Beyer J.
    J Clin Oncol; 2004 Sep 15; 22(18):3713-9. PubMed ID: 15365067
    [Abstract] [Full Text] [Related]

  • 36. Surgery following chemotherapy for metastatic testicular teratoma.
    Whillis D, Coleman RE, Lessells AM, Hargreave TB, Cornbleet MA, Howard GC.
    Br J Urol; 1991 Sep 15; 68(3):292-5. PubMed ID: 1913071
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
    Pizzocaro G, Pasi M, Salvioni R, Zanoni F, Milani A, Piva L.
    Cancer; 1985 Nov 15; 56(10):2399-403. PubMed ID: 2412681
    [Abstract] [Full Text] [Related]

  • 39. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
    Kulkarni RP, Reynolds KW, Newlands ES, Dawson PM, Makey AR, Theodorou NA, Bradley J, Begent RH, Rustin GJ, Bagshawe KD.
    Br J Surg; 1991 Feb 15; 78(2):226-9. PubMed ID: 1707715
    [Abstract] [Full Text] [Related]

  • 40. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
    Studer UE, Fey MF, Calderoni A, Kraft R, Mazzucchelli L, Sonntag RW.
    Eur Urol; 1993 Feb 15; 23(4):444-9. PubMed ID: 7687549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.